Status
Conditions
Treatments
About
The goal of this clinical trial is to test the safety and efficacy of local excision (LE) or non-operative management (NOM) in patients with MRI defined low-risk rectal cancer following neoadjuvant intensity modulated radiotherapy with concurrent capecitabine plus consolidation CapeOX. The main questions it aims to answer are:
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
67 participants in 3 patient groups
Loading...
Central trial contact
Lin Wang, M.D.; Xiaokang Lei, M.D.
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal